Abstract
The warning by the Italian Medicines Agency on the high shortage of azithromycin in the country in January 2022 represents a paradigmatic lesson learnt from improper use of antibiotics during COVID-19 pandemic.
Highlights
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations
Azithromycin Has Been Flying Off the Shelves: The Italian Lesson Learnt from Improper Use of Antibiotics against COVID-19
It can be inferred that azithromycin hoarding represents a symptom of excessive prescribing by healthcare providers, virtually attributable to convincing solicitation by COVID-19 patients or those who are afraid of being infected with SARS-CoV-2
Summary
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Azithromycin Has Been Flying Off the Shelves: The Italian Lesson Learnt from Improper Use of Antibiotics against COVID-19. On 13 January 2022, the Italian Medicines Agency (Agenzia Italiana del Farmaco— AIFA) warned about a high shortage of azithromycin in the country, mainly due to its improper use against COVID-19.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
